Platelet and Red Blood Cell Utilization and Transfusion Independence in Umbilical Cord Blood and Allogeneic Peripheral Blood Hematopoietic Cell Transplants

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 5, 2011, Pages 710-716

  Solh, Melhem ^a   Brunstein, Claudio ^a   Morgan, Shanna ^b   Weisdorf, Daniel ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Blood products in hCT; Hematopoietic cell transplatation; Platelet transfusion; RBC transfusion

Indexed keywords

ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; MYELOMA; THROMBOCYTE TRANSFUSION; UMBILICAL CORD BLOOD;

ADULT; BLOOD PLATELETS; BLOOD TRANSFUSION; CELL COUNT; CORD BLOOD STEM CELL TRANSPLANTATION; ERYTHROCYTES; FANCONI ANEMIA; FEMALE; FETUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; LYMPHOMA; MALE; MINNESOTA; MULTIPLE MYELOMA; NEUTROPHILS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLATELET COUNT; PLATELET TRANSFUSION; PREGNANCY; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 79954595950     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.08.017     Document Type: Article

References (27)

1. Hiemenz J.W. Management of infections complicating allogeneic hematopoietic stem cell transplantation. Semin Hematol 2009, 46:289-312.
2. Osterwalder B., Gratwohl A., Reusser P., Tichelli A., Speck B. Hematological support in patients undergoing allogenetic bone marrow transplantation. Recent Results Cancer Res 1988, 108:44-52.
3. Pihlstedt P., Paulin T., Sundberg B., Nilsson B., Ringden O. Blood transfusion in marrow graft recipients. Ann Hematol 1992, 65:66-70.
4. Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med. 362:600-613.
5. Diedrich B., Remberger M., Shanwell A., Svahn B.M., Ringden O. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 × 10(9) per L versus 30 × 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients. Transfusion 2005, 45:1064-1072.
6. Klumpp T.R., Herman J.H., Innis S., et al. Factors associated with response to platelet transfusion following hematopoietic stem cell transplantation. Bone Marrow Transplant 1996, 17:1035-1041.
7. Nevo S., Fuller A.K., Zahurak M.L., et al. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 × 10(9) or 20 × 10(9) per L. Transfusion 2007, 47:1700-1709.
8. Nevo S., Fuller A.K., Hartley E., Borinsky M.E., Vogelsang G.B. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 × 10(9) and 20 × 10(9) per L. Transfusion 2007, 47:801-812.
9. Gaydos L.A., Freireich E.J., Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 1962, 266:905-909.
10. Rebulla P., Finazzi G., Marangoni F., et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 1997, 337:1870-1875.
11. Wandt H., Frank M., Ehninger G., et al. Link, safety and cost effectiveness of a 10 × 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 × 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998, 91:3601-3606.
12. Aderka D., Praff G., Santo M., Weinberger A., Pinkhas J. Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy. Am J Med Sci 1986, 291:147-151.
13. Gil-Fernandez J.J., Alegre A., Fernandez-Villalta M.J., et al. Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplant 1996, 18:931-935.
14. Zumberg M.S., del Rosario M.L., Nejame C.F., et al. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger. Biol Blood Marrow Transplant 2002, 8:569-576.
15. Nevo S., Vogelsang G.B. Acute bleeding complications in patients after bone marrow transplantation. Curr Opin Hematol 2001, 8:319-325.
16. Gajewski J.L., Johnson V.V., Sandler S.G., Sayegh A., Klumpp T.R. A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation. Blood 2008, 112:3036-3047.
17. Niederwieser D., Maris M., Shizuru J.A., et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003, 101. 1620-1609.
18. Prebet T, Ladaique P, Ferrando M, et al. Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation. Exp Hematol. 38:55-60.
19. Brunstein C.G., Barker J.N., Weisdorf D.J., et al. Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant 2009, 43:935-940.
20. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998, 339:1565-1577.
21. Wagner J.E., Rosenthal J., Sweetman R., et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996, 88:795-802.
22. Matsuno N., Wake A., Uchida N., et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood 2009, 114:1689-1695.
23. Baron F., Storb R., Storer B.E., et al. Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation. J Clin Oncol 2006, 24:4150-4157.
24. Martino R., Caballero M.D., de la Serna J., et al. Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant. Bone Marrow Transplant 2002, 30:63-68.
25. Ivanov V., Faucher C., Mohty M., et al. Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level. Transfusion 2004, 44:501-508.
26. Weissinger F., Sandmaier B.M., Maloney D.G., Bensinger W.I., Gooley T., Storb R. Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings. Blood 2001, 98:3584-3588.
27. Majhail N.S., Mothukuri J.M., Brunstein C.G., Weisdorf D.J. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications. Biol Blood Marrow Transplant 2009, 15:564-573.